Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2014 and based in Wilmington, Delaware, Longview Innovation is a venture capital firm specializing in hard science investments. The firm partners with prestigious North American research institutions and national laboratories to commercialize technologies with disruptive potential. Longview Innovation has backed 7 companies to date.
Longview Innovation invests in pre-seed to Series C companies within the biotech, healthcare, AI, and industrial sectors. Their disciplined investment process emphasizes scientific discovery and aims to establish disruptive commercial capabilities. Collaborations with universities and national labs are central to their strategy, ensuring a strong foundation in advanced scientific research.
Notable portfolio companies include Carisma Therapeutics, which focuses on engineered macrophages; Exyn Technologies, specializing in robotic autonomy for industrial data collection; and MOBILion Systems, which addresses analytical complexity. Other investments include EnaChip, Lumiode, Optimeos Life Sciences, and Somalytics.
Email your pitch deck to Hello@LongviewInnovation.com for consideration.
Yes, Longview Innovation often leads investment rounds, particularly in the early stages of company development.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their scientific focus.
Specific fund size details are not disclosed, but the firm actively manages investments across multiple stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.